Abstract:BackgroundTranscription factor Sp1 is multifaceted, with the ability to function as an oncogene or a tumor suppressor, depending on the cellular context. We previously reported that Sp1 is required for the transcriptional activation of the key oncogenes in nasopharyngeal carcinoma (NPC), including B-lymphoma mouse Moloney leukemia virus insertion region 1 (Bmi1) and centromere protein H (CENPH), but the role of Sp1 and its underlying mechanisms in NPC remained largely unexplored. The objective of this study was to investigate the cellular function of Sp1 and to verify the clinical significance of Sp1 as a potential therapeutic target in NPC.MethodsThe levels of Sp1 in the normal primary nasopharyngeal epithelial cells (NPECs) and NPC cell lines were analyzed by Quantitative Real-time RT-PCR (qRT-PCR) and Western blot. The location and expression of Sp1 in the NPC tissues were detected by immunohistochemistry staining (IHC). The effect of Sp1 knockdown on the cell proliferation, clonogenicity, anchorage-independent growth and the stem-cell like phenotype in NPC cells were evaluated by MTT, flow cytometry, clonogenicity analysis and sphere formation assay.ResultsThe mRNA and protein levels of Sp1 were elevated in NPC cell lines than in the normal primary NPECs. Higher expression of Sp1 was found in NPC tissues with advanced clinical stage (P = 0.00036). Either inhibition of Sp1 activity by mithramycin A, the FDA-approved chemotherapeutic anticancer drug or Sp1 silencing by two distinct siRNA against Sp1 suppressed the growth of NPC cells. Mechanism analysis revealed that Sp1 silencing may suppress cell proliferation, clonogenicity, anchorage-independent growth and the stem-cell like phenotype through inducing the expression of p27 and p21, and impairing the expressions of the critical stem cell transcription factors (SCTFs), including Bmi1, c-Myc and KLF4 in NPC cells.ConclusionsSp1 was enriched in advanced NPC tissues and silencing of Sp1 significantly inhibited cell proliferation, clonogenicity, anchorage-independent growth and the stem-cell like phenotype of NPC cells, suggesting Sp1 may serve as an appealing drug target for NPC.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of transcription factor Sp1 in nasopharyngeal carcinoma (NPC) and its clinical significance as a potential therapeutic target. Specifically, the researchers aimed to: 1. **Analyze the expression level of Sp1**: Detect the mRNA and protein levels of Sp1 in normal primary nasopharyngeal epithelial cells (NPECs) and nasopharyngeal carcinoma cell lines by quantitative real - time reverse transcription polymerase chain reaction (qRT - PCR) and Western blot techniques. 2. **Evaluate the expression of Sp1 in tumor tissues**: Use immunohistochemistry (IHC) to detect the location and expression level of Sp1 in nasopharyngeal carcinoma tissues and analyze its relationship with clinical staging. 3. **Study the effects of Sp1 knockdown on cell proliferation, clonogenic ability and anchorage - independent growth**: Evaluate the changes in the proliferation ability, clonogenic ability and anchorage - independent growth ability of nasopharyngeal carcinoma cells after Sp1 knockdown by MTT assay, clonogenic assay and soft agar assay. 4. **Explore the effects of Sp1 knockdown on the stem - cell - like phenotype**: Study whether Sp1 knockdown affects the stem - cell - like phenotype of nasopharyngeal carcinoma cells by sphere - forming assay and detecting the expression of stem - cell markers. 5. **Reveal the molecular mechanism of Sp1 knockdown**: Explore the specific mechanism by which Sp1 knockdown inhibits cell proliferation and clonogenesis by detecting the expression changes of cell - cycle regulatory factors such as p27 and p21, and key stem - cell transcription factors such as Bmi1, c - Myc and KLF4. The research results show that Sp1 is highly expressed in advanced nasopharyngeal carcinoma tissues, and the knockdown of Sp1 significantly inhibits the proliferation, clonogenic ability and anchorage - independent growth ability of nasopharyngeal carcinoma cells, and at the same time reduces the expression of stem - cell markers. These findings suggest that Sp1 may be a potential therapeutic target for nasopharyngeal carcinoma.

Down-regulation of Sp1 suppresses cell proliferation, clonogenicity and the expressions of stem cell markers in nasopharyngeal carcinoma

The Developmental Transcription Factor IRF6 Attenuates ABCG2 Gene Expression and Distinctively Reverses Stemness Phenotype in Nasopharyngeal Carcinoma.

Sp1 is Over-Expressed in Nasopharyngeal Cancer and is a Poor Prognostic Indicator for Patients Receiving Radiotherapy.

Src-1 and SP2 Promote the Proliferation and Epithelial–mesenchymal Transition of Nasopharyngeal Carcinoma

Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma.

Epigenetic Mediated Zinc Finger Protein 671 Downregulation Promotes Cell Proliferation and Tumorigenicity in Nasopharyngeal Carcinoma by Inhibiting Cell Cycle Arrest.

HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma

Pin2 Telomeric Repeat Factor 1-Interacting Telomerase Inhibitor 1 (pinx1) Inhibits Nasopharyngeal Cancer Cell Stemness: Implication for Cancer Progression and Therapeutic Targeting

SPEN Induces Mir-4652-3p to Target HIPK2 in Nasopharyngeal Carcinoma

FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma

Notch inhibition suppresses nasopharyngeal carcinoma by depleting cancer stem-like side population cells.

High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma

Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.

Induction of interleukin-6 by SPZ1-mediated Wnt5a signaling boosts progression of nasopharyngeal carcinoma cells

SOX1 down-regulates β-catenin and reverses malignant phenotype in nasopharyngeal carcinoma

E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma.

Blockage Of Ssrp1/Ets-1/Pim-3 Signalling Enhances Chemosensitivity Of Nasopharyngeal Carcinoma To Docetaxel In Vitro

Data from Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC

Dysregulation of the PI3K/Akt Signaling Pathway Affects Cell Cycle and Apoptosis of Side Population Cells in Nasopharyngeal Carcinoma.

Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation

Lplunc1 Inhibits Nasopharyngeal Carcinoma Cell Growth Via Down-Regulation of the Map Kinase and Cyclin D1/E2f Pathways